Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
Active, not recruiting · NCT02374242 · Registry updated 2025-12-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases | Brain Metastases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, brain disorder, central nervous system cancer, central nervous system disorder, melanocytic neoplasm, melanoma, neoplasm, nervous system disorder, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 2 | 2025-12-10 | NCT02374242 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Melanoma and Skin Cancer Trials Limited | 10 |
| Melanoma Institute Australia | 11 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Melanoma Institute Australia | Wollstonecraft | Australia | 19 |
| Peter MacCallum Cancer Centre | East Melbourne | Australia | 4 |
| Princess Alexandra Hospital | Woolloongabba | Australia | 106 |
| Royal Adelaide Hospital | Adelaide | Australia | 132 |